3 Reasons Why Rare Disease Marketing Strategies Need To Start With Inside Sales
PharmaKinnex
APRIL 28, 2022
3 Reasons Why Rare Disease Marketing Strategies Need To Start With Inside Sales April 28, 2022. PharmaK. Over the past few years, rare disease drugs have seen an increase in research and development from the big pharmaceutical companies. Some of the many reasons for this are that rare disease drugs benefit from speedier clinical development timelines, lower commercialization costs, higher market valuation, and financial inflows for improving diagnosis and treatment approaches.
Let's personalize your content